Latest News of NVCT
Insiders hold 65% of Nuvectis Pharma, Inc. (NASDAQ:NVCT), and they've been buying recently
By Yahoo! Finance |
3 months ago
Nuvectis Pharma's significant insider control indicates vested interests in company growth. Insiders owning 65% of shares show commitment and potential stock price rise. Institutional investors also h...